Early virological failure with cabotegravir/rilpivirine

J Antimicrob Chemother. 2024 May 2;79(5):1193-1194. doi: 10.1093/jac/dkae044.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents* / therapeutic use
  • Drug Combinations
  • HIV Infections* / drug therapy
  • HIV-1 / drug effects
  • Humans
  • Male
  • Middle Aged
  • Rilpivirine* / therapeutic use
  • Treatment Failure
  • Viral Load / drug effects

Substances

  • Anti-HIV Agents
  • Rilpivirine
  • cabotegravir, rilpivirine drug combination
  • Drug Combinations